Eric Topol

Mentioned in 1 episode

"We've already seen how GLP-1 drugs do that before any weight loss. So that should work well in people who aren't even obese. And we've seen how that can prevent and preserve ejection fraction heart failure, which is half of all heart failure — GLP-1s prevent that."

Mentioned in 1 episode

"This is a University of Oxford spinout. I think it's called Carista. They're going to have that available soon. If you have inflammation without narrowing, you could have a 15-fold risk of a heart attack. So that's when you use that as a metric."

Mentioned in 1 episode

"You can do a retinal AI exam — I have a picture of the retina and you do AI on it and it tells you when you're going to have Alzheimer's if you're going to have Alzheimer's 5 to 7 years in advance. The retina also tells if you're going to have heart disease or a stroke in advance. It will even tell your calcium score of your heart arteries through your retina. It's remarkable and we should — that should be widely available."

Mentioned in 1 episode

"We can get a simple lipid panel, add LP(a), so a little more than what is the standard lipid panel — we can also get a polygenic risk score, very inexpensive, we can also get a heart clock, and we can get inflammation markers. Now you have the full stack."